Case report demonstrates effective B-cell depletion therapy in managing three autoimmune diseases, suggesting a potential treatment pathway.
To describe a rare case of coexisting neuromyelitis optica spectrum disorder (NMOSD), systemic lupus erythematosus (SLE), and idiopathic thrombocytopenic purpura (ITP), successfully managed with B-cell depletion therapy (inebilizumab), and systematically review the literature on NMOSD coexistence with other autoimmune diseases (AD)s.
No takes yet. Share an insight, caveat, or question.
Alquraan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: